Indo-Bangla Pharmaceuticals Limited (DSE:IBP)
Bangladesh · Delayed Price · Currency is BDT 14.10
+0.20 (1.44%)
At close: Nov 4, 2026
DSE:IBP Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jul '22 Jul 1, 2022 | Jul '21 Jul 1, 2021 |
| 1,638 | 1,522 | 1,546 | 1,975 | 2,036 | 2,186 | |
Market Cap Growth | 23.68% | -1.50% | -21.77% | -2.97% | -6.88% | -1.96% |
Enterprise Value | 1,655 | 1,544 | 1,570 | 2,047 | 2,079 | 2,262 |
Last Close Price | 14.10 | 13.08 | 13.27 | 16.96 | 17.75 | 18.68 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jul '22 Jul 1, 2022 | Jul '21 Jul 1, 2021 |
PE Ratio | - | - | - | 234.98 | 80.87 | 16.23 |
PS Ratio | 6.77 | 8.27 | 8.75 | 5.28 | 4.20 | 2.80 |
PB Ratio | 1.12 | 1.05 | 0.98 | 1.22 | 1.25 | 1.35 |
P/TBV Ratio | 1.12 | 1.05 | 0.98 | 1.22 | 1.25 | 1.35 |
P/FCF Ratio | 28.84 | 26.30 | 65.38 | 46.03 | 42.77 | - |
P/OCF Ratio | 28.55 | 26.05 | 45.77 | 27.08 | 23.33 | 14.48 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jul '22 Jul 1, 2022 | Jul '21 Jul 1, 2021 |
EV/Sales Ratio | 6.84 | 8.38 | 8.89 | 5.47 | 4.29 | 2.89 |
EV/EBITDA Ratio | 68.62 | 350.91 | 328.22 | 30.53 | 27.74 | 10.81 |
EV/EBIT Ratio | - | - | - | 71.35 | 58.07 | 13.05 |
EV/FCF Ratio | 29.13 | 26.67 | 66.42 | 47.69 | 43.67 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jul '22 Jul 1, 2022 | Jul '21 Jul 1, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.03 | 0.05 | 0.05 |
Debt / EBITDA Ratio | 0.75 | 4.55 | 5.06 | 0.65 | 1.01 | 0.41 |
Debt / FCF Ratio | 0.32 | 0.35 | 1.02 | 1.02 | 1.58 | - |
Net Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 |
Net Debt / EBITDA Ratio | 0.69 | 3.56 | 2.89 | 0.48 | 0.62 | 0.24 |
Net Debt / FCF Ratio | 0.29 | 0.27 | 0.58 | 0.75 | 0.98 | -1.00 |
Asset Turnover | 0.14 | 0.10 | 0.10 | 0.20 | 0.26 | 0.43 |
Inventory Turnover | 1.54 | 1.23 | 0.92 | 1.55 | 1.76 | 2.39 |
Quick Ratio | 2.33 | 1.71 | 2.12 | 1.88 | 1.61 | 1.65 |
Current Ratio | 4.23 | 3.62 | 4.95 | 4.26 | 3.50 | 3.57 |
Return on Equity (ROE) | -0.95% | -2.43% | -2.56% | 0.52% | 1.55% | 8.57% |
Return on Assets (ROA) | -0.14% | -0.85% | -0.80% | 0.95% | 1.18% | 5.95% |
Return on Invested Capital (ROIC) | -0.26% | -1.57% | -1.46% | 0.59% | 1.70% | 8.67% |
Return on Capital Employed (ROCE) | -0.20% | -1.50% | -1.40% | 1.60% | 2.10% | 10.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jul '22 Jul 1, 2022 | Jul '21 Jul 1, 2021 |
Earnings Yield | -0.88% | -2.42% | -2.65% | 0.43% | 1.24% | 6.16% |
FCF Yield | 3.47% | 3.80% | 1.53% | 2.17% | 2.34% | -2.26% |
Dividend Yield | 0.11% | 0.11% | 0.07% | - | 0.57% | 2.08% |
Payout Ratio | - | - | - | 123.72% | 98.46% | 19.97% |
Buyback Yield / Dilution | 2.37% | - | - | - | -2.17% | - |
Total Shareholder Return | 2.48% | 0.11% | 0.07% | - | -1.60% | 2.08% |